1-12 of 12
venetoclax
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.
https://doi.org/10.1182/hematology.2019000032
Published: 2019
Journal Articles

Relapsed disease and aspects of undetectable MRD and treatment discontinuation

Barbara Eichhorst, Moritz Fürstenau, Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 482–489.
https://doi.org/10.1182/hematology.2019000070
Published: 2019
Journal Articles

Single-agent and combination biologics in acute myeloid leukemia

Guillaume Richard-Carpentier, Courtney D. DiNardo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 548–556.
https://doi.org/10.1182/hematology.2019000059
Published: 2019
Journal Articles

Treatment-naive CLL: lessons from phase 2 and phase 3 clinical trials

Jennifer A. Woyach
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 476–481.
https://doi.org/10.1182/hematology.2019001321
Published: 2019
Journal Articles

Clonal dynamics in chronic lymphocytic leukemia

Catherine Gutierrez, Catherine J. Wu
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 466–475.
https://doi.org/10.1182/hematology.2019000367
Published: 2019
Journal Articles

Selecting Frontline Therapy for CLL in 2018

Nitin Jain
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 242–247.
https://doi.org/10.1182/asheducation-2018.1.242
Published: 2018
Journal Articles

Relapsed CLL: sequencing, combinations, and novel agents

Jennifer R. Brown
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 248–255.
https://doi.org/10.1182/asheducation-2018.1.248
Published: 2018
Journal Articles

The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment

Gianluca Gaidano, Davide Rossi
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 329–337.
https://doi.org/10.1182/asheducation-2017.1.329
Published: 2017
Journal Articles

How should we sequence and combine novel therapies in CLL?

Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 346–353.
https://doi.org/10.1182/asheducation-2017.1.346
Published: 2017
Journal Articles

Safety profiles of novel agent therapies in CLL

Inhye E. Ahn, Matthew S. Davids
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 354–357.
https://doi.org/10.1182/asheducation-2017.1.354
Published: 2017
Journal Articles

Sequencing of chronic lymphocytic leukemia therapies

Jacqueline C. Barrientos
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 128–136.
https://doi.org/10.1182/asheducation-2016.1.128
Published: 2016
Journal Articles

Prognostic markers and standard management of chronic lymphocytic leukemia

Stephan Stilgenbauer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 368–377.
https://doi.org/10.1182/asheducation-2015.1.368
Published: 2015